Vortioxetine-Induced Amenorrhea: a Case Report
dc.authorid | Kurhan, Faruk/0000-0003-3718-0458 | |
dc.authorid | Isik, Mesut/0000-0003-1707-7402 | |
dc.authorscopusid | 56717384700 | |
dc.authorscopusid | 57217966676 | |
dc.authorscopusid | 56709613300 | |
dc.authorscopusid | 36718861100 | |
dc.authorwosid | Ulkevan, Tuba/Mbv-6469-2025 | |
dc.authorwosid | Kurhan, Faruk/Ivu-6511-2023 | |
dc.contributor.author | Isik, Mesut | |
dc.contributor.author | Kurhan, Faruk | |
dc.contributor.author | Ulkevan, Tuba | |
dc.contributor.author | Ozdemir, Pinar Guzel | |
dc.date.accessioned | 2025-05-10T17:37:18Z | |
dc.date.available | 2025-05-10T17:37:18Z | |
dc.date.issued | 2022 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Isik, Mesut; Kurhan, Faruk; Ulkevan, Tuba; Ozdemir, Pinar Guzel] Van Yuzuncu Yil Univ, Dept Psychiat, Fac Med, Van, Turkey | en_US |
dc.description | Kurhan, Faruk/0000-0003-3718-0458; Isik, Mesut/0000-0003-1707-7402 | en_US |
dc.description.abstract | Background: Vortioxetine is a novel multimodal antidepressant for the treatment of major depressive disorders and is widely used in clinical practice. Vortioxetine has a safe profile. However, there are case reports of other adverse effects in the literature. In this article, a case of amenorrhea due to vortioxetine is presented. Case: The patient is 36 years old, married, female, and is an anesthesiologist. She applied to the psychiatric outpatient clinic with symptoms of major depression. Vortioxetine was initiated at 10 mg/d and then gradually increased to 20 mg/d. She had regular menstruation until now. However, she did not menstruate after taking vortioxetine. The patient used vortioxetine for 3months and never had a period. Pregnancy test and other tests to investigate organic etiology were normal. Twoweeks after discontinuation of vortioxetine, the patient had a menstrual period. Conclusions: Further research is needed on the relationship and possible mechanisms between vortioxetine and amenorrhea. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1097/WNF.0000000000000490 | |
dc.identifier.endpage | 8 | en_US |
dc.identifier.issn | 0362-5664 | |
dc.identifier.issn | 1537-162X | |
dc.identifier.issue | 1 | en_US |
dc.identifier.pmid | 35029863 | |
dc.identifier.scopus | 2-s2.0-85123651377 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 7 | en_US |
dc.identifier.uri | https://doi.org/10.1097/WNF.0000000000000490 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/14327 | |
dc.identifier.volume | 45 | en_US |
dc.identifier.wos | WOS:000968226900002 | |
dc.identifier.wosquality | Q4 | |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Vortioxetine | en_US |
dc.subject | Amenorrhea | en_US |
dc.subject | Adverse Effect | en_US |
dc.title | Vortioxetine-Induced Amenorrhea: a Case Report | en_US |
dc.type | Article | en_US |